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Abstract 
The COVID-19 pandemic is having a profound effect on all aspects of society, including 
mental health as well as physical health. We explore the psychological, social and 
neuroscience impacts of COVID-19, and set out immediate priorities and longer-term 
strategies for mental health science research. These priorities were informed by surveys 
of the public and an expert panel convened by the UK Academy of Medical Sciences and 
the mental health research charity, MQ: Transforming Mental Health, in the first weeks 
of the pandemic in the UK in March 2020. We urge UK research funding agencies to work 
with researchers, people with lived experience and others to establish a high level co-
ordination group to ensure that these research priorities are addressed, and to allow new 
ones to be identified over time. The need to maintain high quality research standards is 
imperative. International collaboration and a global perspective will be beneficial. An 
immediate priority is collecting data on the mental health impacts of the COVID-19 
pandemic across the whole population and vulnerable groups, and on brain function, 
cognition and mental health for COVID-19 patients. There is an urgent need for research 
to address how mental health consequences for vulnerable groups can be mitigated 
under pandemic conditions, as well as on the impact of repeated media consumption and 
health messaging around COVID-19. Discovery, evaluation and refinement of 
mechanistically-driven interventions to address the psychological, social and 
neuroscientific aspects of this pandemic are required. Rising to this challenge will require 
integration across disciplines and sectors, and should be done together with people with 
lived experience. New funding will be required to meet these priorities, but it can be 
efficiently leveraged by the UK’s world-leading infrastructure. 
 
 
1. Introduction  
 
It is already evident that the direct and indirect psychological and social impacts of the 
pandemic are pervasive, and could affect mental health now and into the future. The 
pandemic is occurring against the backdrop of increased prevalence of mental health 
issues in the UK in recent years in some groups1,2. Furthermore, SARS-CoV2, the virus 
causing COVID-19, might infect the brain or trigger immune responses that have 
additional adverse effects on brain function and mental health in COVID-19 patients.   
 
Research funders and researchers must deploy resources to understand the 
psychological, social and biological impacts of the COVID-19 pandemic. Mobilisation now 
will allow us to apply the learnings gained to any future periods of increased infection 
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and lockdown, which will be particularly important for frontline workers, and for 
vulnerable groups. We propose a framework for the prioritization and coordination of 
essential, policy-relevant psychological, social and neuroscience research, to ensure that 
any investment is efficiently targeted on the critical mental health science questions as 
the pandemic unfolds. We use the term ‘mental health sciences’ to reflect the many 
different disciplines, including but not limited to psychology, psychiatry, clinical 
medicine, behavioural and social sciences and neuroscience, that will need to work 
together in a multidisciplinary fashion together with people with lived experience to 
address these research priorities.  
 
The UK has powerful advantages in mounting a successful response to the pandemic, 
including strong existing research infrastructure and expertise, but the community must 
act rapidly and collaboratively if it is to deal with the growing threats to mental health. A 
fragmented research response, characterized by small-scale and localized initiatives, will 
not yield the clear insights necessary to guide policy-makers or the public. Rigorous 
scientific and ethical review of protocols and results remains the cornerstone of 
safeguarding participants and upholding research standards. Deploying a mental health 
science perspective3 to the pandemic will also inform population-level behaviour change 
initiatives aimed at reducing the spread of the virus. International comparisons will be 
especially helpful in this regard. In this paper, we explore the psychological, social and 
neuroscience impacts of COVID-19, and set out clear, immediate priorities and longer-
term strategies for each of these aspects. 
 
We also conducted surveys of the public and people with lived experience of mental ill-
health. The general population survey, conducted by Ipsos MORI, revealed widespread 
concerns about the impact of social isolation or social distancing on wellbeing; increased 
levels of anxiety, depression, stress and other negative feelings; and concern about the 
practical implications of pandemic response including financial difficulties. The prospect 
of becoming physically unwell with COVID-19 ranked lower than these issues related to 
the social response to the pandemic. The MQ stakeholder survey of people with lived 
experience of a mental health issue likewise highlighted general concerns about social 
isolation and increased levels of anxiety and depression. More specifically, stakeholders 
frequently expressed concerns about exacerbation of pre-existing mental health issues, 
greater difficulty in accessing mental health support and services under pandemic 
conditions, and impact of COVID-19 on the mental health of family members, especially 
children and older people. Both surveys are reported in full in the web appendix. These 
findings, combined with the published scientific literature, informed the development of 
our research priorities. They represent a snapshot of the current situation, but will need 
to be repeated more rigorously over the course of the pandemic. 
 
Panel 1: Methodology 
 
This article summarises the priorities put forward by an interdisciplinary group of 24 
world-leading experts, including people with lived experience, from across the bio-
psycho-social spectrum of expertise in mental health science in March/April 2020. The 
experts were convened by the UK Academy of Medical Sciences and the mental health 
research charity, MQ: Transforming Mental Health. Members participated in an individual 
capacity, not as representatives of their organisations. A coordinating group of seven 
experts met daily over a period of two weeks to develop the research priorities, informed 
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by input from the expert advisory group. Given the need to develop the research 
priorities rapidly to inform immediate funding priorities, extended evidence gathering 
and consultation was not possible. However, we are confident that the wide breadth of 
expertise on the expert group and their leading roles in their respective fields provide a 
wide-ranging and comprehensive view of the mental health and neuroscience research 
priorities.  
 
Lived experience was incorporated by four mechanisms. First, three lived experience 
representatives provided input via the expert advisory group. Second, an online survey 
collected data on people’s two biggest concerns about the mental health and wellbeing 
implications of the COVID-19 pandemic, as well as coping strategies. The survey was 
promoted via email to MQ’s supporter network as well as via social media. In total, 
2,198 people completed the survey, submitting 4,350 concerns about the mental health 
impacts of the COVID-19 pandemic and 1,987 responses about what has helped 
maintain mental health and wellbeing during the pandemic. A thematic analysis of the 
full dataset was carried out. Third, two questions were asked on Ipsos MORI’s online 
Omnibus survey to collect data on people’s concerns about the impact of COVID-19 on 
mental wellbeing, as well as what is helping people’s mental wellbeing at this time. In 
total, 1,099 interviews were completed with adults aged between 16 and 75 across 
England, Wales and Scotland. Quotas were set and data were weighted to the offline 
population to ensure a nationally representative sample by gender, age and region. 
Statistical analysis was carried out and any sub-group differences included are 
statistically significant at a 95% confidence interval unless stated otherwise. A summary 
report of the findings of both surveys and further methodological details can be found in 
the web appendix. The Ipsos MORI tabular data can be found on its website4. Fourth, the 
manuscript was peer-reviewed by a reviewer with lived experience of a mental health 
issue. We acknowledge the limitations of our surveys, including the representativeness 
of the MQ sample, the short timescale for input and the representativeness of online 
populations. We also acknowledge the limited evidence gathering and opportunity for 
wider consultation of people with lived experience. However, combined, these four 
mechanisms of collecting input from people with lived experience provide important 
insight into people’s concerns about the impact of COVID-19 on mental health and 
coping strategies within the very limited timeframe.  
 
A living systematic map5 is tracking emerging empirical studies, systematic reviews, and 
modelling on COVID-19. As of 1st April 2020, 643 were records identified in the 




2. Psychology and individual factors: researching the impact of COVID-19 on 
mental health  
 
In this section, we focus on the psychological and individual processes in COVID-19, 
such as cognition, emotion and behaviour, which affect mental health. Two areas that 
require urgent research prioritisation are:  
 
(1)What is the impact of COVID-19 on risk of anxiety, depression, self-harm, 
and suicide, and other mental health issues?  
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While a rise in anxiety symptoms and coping responses to stress are expected during 
these extraordinary circumstances, there is a risk that prevalence of clinically-relevant 
levels of anxiety, depression and other harmful behaviours, such as suicide and self-
harm, will increase. It is important to note, however, that a rise in suicide is not 
inevitable especially with national mitigation efforts16.  
 
The potential fallout of an economic downturn on mental health is likely to be profound 
on those directly affected as well as on their caregivers. The SARS epidemic was 
associated with a 30% increase in suicide among those aged 65 and older; around 50% 
of recovered patients remained anxious; and 29% of health care workers experienced 
probable emotional distress 17–19. Patients who survived severe and life-threatening 
illness were at risk of post-traumatic stress disorder and depression18,19. Many of the 
anticipated consequences of quarantine13 and associated social/physical distancing 
measures are themselves key risk factors for mental health issues. These include suicide 
and self-harm, alcohol and substance abuse, gambling, domestic and child abuse, as well 
as psychosocial risks, such as social disconnection, lack of meaning or anomie, 
entrapment, cyberbullying, feeling a burden, financial stress, bereavement, loss, 
unemployment, homelessness and relationship breakdown20–22.  
 
A major adverse consequence of the COVID-19 pandemic is likely to be increased social 
isolation and loneliness (as reflected in our surveys), which are strongly associated with 
anxiety, depression, self-harm and suicide attempts across the lifespan23,24. Tracking 
loneliness and intervening early are important priorities. Critically, reducing sustained 
feelings of loneliness is a candidate mechanism to protect against suicide, self-harm and 
emotional problems25,26. Social isolation and loneliness are distinct and may represent 
different risk pathways. 
 
To inform management of the pandemic it is vital to understand the socioeconomic 
impact of the policies used to manage the pandemic, which will inevitably have serious 
effects on mental health by increasing unemployment, financial insecurity and 
poverty27,28. Involvement of people with lived experience and rapid qualitative research 
with diverse people and communities may help to identify ways in which this negative 
impact might be alleviated. Achieving the right balance between infection control and 
mitigation of these negative socioeconomic impacts must be considered29.  
 
 
Immediate research priorities 
 
Monitor and report rates of anxiety, depression, self-harm, suicide, as well as 
other mental health issues both to understand mechanisms and critically to 
inform interventions. This should be across the general population and vulnerable 
groups, including frontline workers. Monitoring must go beyond NHS record linkage to 
capture the real incidence in the community as self-harm may become more hidden. We 
must harness existing datasets and ongoing longitudinal studies, and also establish new 
cohorts with new ways of recording including detailed psychological factors25,30. 
Techniques assessing moment to moment changes in psychological risk factors should be 
embraced .  
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Longer-term strategic research programmes 
 
Given the unique circumstances of COVID-19, data will be vital to determine causal 
mechanisms associated with poor mental health30,31, including loneliness and 
entrapment. To optimize effectiveness, psychological treatments need to be 
mechanistically-informed, that is both causally associated with poor mental health and 
modifiable by an intervention30. A ‘one-size fits all’ response will not suffice, as the 
effectiveness of interventions can vary across groups25,32–35. Digital psychological 
interventions that are mechanistically informed, alongside better 
understanding of the buffering effects of social relationships during stressful 
events, are required in the long-term. The digital response is crucial36–38, not only 
because of social isolation measures but also because less than a third of people who die 
by suicide have been in contact with mental health services in the 12 months before 
death39. Digital interventions for anxiety, depression, self-harm and suicide include: 
information provision; connectivity and triage; automated and blended therapeutic 
interventions, such as apps and online programmes; phone calls and messages to reach 
those with more limited digital resources (digital poverty)40; suicide risk assessments; 
chatlines and forums; and technologies that can be used to monitor risk either passively 
or actively. The digital landscape extends beyond apps and requires an evidence-base. 
Artificial intelligence driven adaptive trials could help evaluate effectiveness while digital 
phenotyping could be helpful to ascertain early warning signs for mental ill health41.  
 
Looking beyond digital interventions, as not everyone has access to them (e.g. digital 
poverty), it is important to ascertain what other mechanistically-based psychological 
interventions are effective and for whom30,42. Risks and buffers for loneliness should be a 
focal target in interventions to protect wellbeing. The longer-term consequences of 
COVID-19 on the young and older generations (and other high risk groups including the 
frontline workforce, those with existing mental health conditions, and caregivers) are 
also unknown and must be a priority.   
 
(2)How do individuals build optimal structures for a mentally healthy life 
that works for them in the wake of COVID-19 and social/physical 
distancing? 
 
The optimal structure of a mentally healthy life for individuals in the wake of COVID-19 
needs to be mapped out. This will vary as a function of background and individual 
circumstances. Changes in sleep and lifestyle behaviours influence our mental health and 
stress response. Understanding the effective, individualized ways of coping in such a 
situation is of paramount importance43–45. The social and personal resources (e.g. seeing 
family and getting sufficient sleep) available to individuals can be important resilience-
related factors for mitigating mental health difficulties under particularly stressful 
circumstances46. We need research to foster positive social resources, resilience and 
altruism.  
 
Immediate research priorities 
 
Understanding how frontline health and social care staff and their families can 
be supported to optimize coping strategies could mitigate symptoms of stress, 
and facilitate the implementation of preventative interventions in future47,48. 
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Under COVID-19 it is important that health and social care workers are supported to stay 
in work; the personal, social and economic benefits are vast. Personalized psychological 
approaches are likely to be a key component to address complex mental health 
conditions, coping and prevention30. Given the association between sleep disturbance 
and mental health49, research on mitigating the impact of such changes on our mental 
health and stress response is required. Indeed, there is an established relationship 
between the latter and suicide risk50.    
 
Longer-term strategic research programmes 
 
Develop novel interventions to protect mental wellbeing, including those based 
on positive mechanistic-based components (i.e. causal, modifiable factors) 
such as altruism and prosocial behaviour. This could include increased opportunities 
to elicit community support51,52; exercise53, social activities54, training in assertiveness 
and conflict resolution55; and group interventions that provide support through peers56. 
 
The inclusion of altruism in UK Government health messages has likely impacted 
positively on wellbeing compared to compulsory orders to stay at home47. Key research 
questions include: What altruism-based psychological interventions can be developed for 
mental wellbeing derived from theories of altruism and prosocial behaviour? What can be 
learned from the large-scale roll-out of volunteer-based psychological interventions that 
will optimise the benefits to individuals and society?  
 
Home working, loss of employment and social/physical distancing have abruptly 
interrupted many social opportunities important to physical and psychological health. It 
is important to research the mental health dimension of online life, and investigate how 
changes in engagement with gaming and online platforms might inform interventions 
aimed at improving mental health. We must rapidly learn from successful existing 
strategies to maintain and build social resources and resilience, as well as 
promote good mental health, in specific populations moving forward. 
 




Immediate actions Longer term strategic 
programmes 
The Lancet Psychiatry Personal View: DRAFT 19 FOR RE-SUBMISSION 
07 April 2020 
8 
 
What is the impact 
of COVID-19 on 
risk of anxiety, 
depression, and 





Improve monitoring and 
reporting of the rates of 
anxiety, depression, self-
harm, suicide as well as 
other mental health issues 
 
 
Determine the efficacy of 
mechanistically-based 
digital and non-digital 
interventions and evaluate 
optimal model(s) of 
implementation 
Determine the mechanisms (e.g. 
entrapment and loneliness) that 
explain the rates of anxiety, 
depression, self-harm and suicide 
 
Understand the role of 
psychological factors in buffering 
the effect of social context on 
mental health issues 
 
Ascertain the longer-term 
consequences on wellbeing of 
COVID-19 on the young and older 
generations (and vulnerable 
groups) 
What is the 
optimal structure 
for a mentally 
healthy life in the 






psychological support is 
available to support 
frontline medical and 






(e.g. sleep, nutrition) and 
structural (e.g. rotas) 
factors that protect as 




Develop novel interventions to 
protect mental wellbeing, 
including those based on positive 
mechanistic-based components 
such as altruism and prosocial 
behaviour and understanding of 
online life  
 
Understand how we optimize 
positive social resources and 
enhance resilience in the face of 
stress 
 
Establish the effects of altruism 
on mental health and wellbeing in 
the wake of COVID-19 
 
 
3. Social and population factors: the impact of COVID-19 on mental health  
 
Population level factors, such as the impact of social distancing measures (more recently 
being re-described as physical distancing57) and other necessary public health measures, 
affect mental health within a syndemics approach (Table 2). By syndemics we mean 
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intersecting global trends among demographics (e.g. aging, rising inequality) and health 
conditions (e.g. chronic diseases, obesity) that yield resultant co-morbidities. These 
interacting health effects and societal forces that fuel them combine to form syndemics, 
or complex knots of health determinants58. Research priorities around COVID-19 require 
us to embrace complexity by deploying multidimensional perspectives. Three areas that 
require urgent research prioritisation are:   
 
(1)What are the mental health consequences of the COVID-19 lock down 
and social isolation for vulnerable groups, and how can these be 
mitigated under pandemic conditions? 
 
We do not yet know the immediate or long term consequences of the COVID-19 lock 
down and social isolation on mental health. While worries and uncertainties about a 
pandemic are common, for some they can cause undue distress as well as impairment to 
social and occupational functioning13,59,60. Across society, a sense of loss can stem from 
losing direct social contacts, and also range from loss of loved ones, to loss of 
employment, educational opportunities, recreation, freedoms and supports.  Existing 
evidence suggests some measures taken to control the pandemic may have a 
disproportionate effect on those most vulnerable (Panel 2).  
 
Vulnerable groups include those with pre-existing mental and/or physical health issues 
including those with SMI (Severe Mental Illnesses), recovered individuals, and those who 
become mentally unwell, for example in response to anxiety surrounding the 
pandemic47,61,62 (Panel 2). Therefore, loss of access to mental health support, alongside 
loss of positive activities, will increase vulnerability during COVID-19 lockdown. 
Increased anxiety and depression in response to the outbreak has been widely 
reported63. Health workers who come in close contact with the virus and are exposed to 
traumatic events such as death and dying, and also making highly challenging decisions, 
are particularly at risk of stress responses9.  
 
The pandemic intersects with rising mental health issues in childhood and 
adolescence2,64,65. Ascertaining and mitigating effects of school closures for youth 
seeking care is urgent and essential, given school is often a first port of call64,66, 
considering vulnerabilities such as special educational needs and developmental 
disorders, and finding therapeutic levers67. For the older population, promoting good 
mental health is important during self-isolation, which can be compounded by lifestyle 
restrictions, exacerbated loneliness, co-morbidities such as dementia, feelings of worry 
and guilt for utilizing resources68. There is an acute need to identify remotely-delivered 
interventions that support those at risk of abuse69,70.  
 
Immediate research priorities 
 
To reduce mental health issues and boost resilience generally, and in 
vulnerable groups in particular, a co-ordinating mechanism for pandemic 
mental health interventions  is required for (1) the agile identification of 
interventions that can be repurposed, alongside identification of gaps which 
will require bespoke de novo design, and (2) the evaluation and roll-out of 
bespoke remotely-delivered interventions. By the term ‘intervention’, we mean 
interventions of all sorts that make a difference to mental health including population 
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level policy, occupational guidelines, psychological interventions (see earlier section) and 
so forth. 
 
We need to rapidly gather high quality data to ascertain effects over time. Innovative 
research is needed to establish ways to mitigate and manage mental health risks and 
inform interventions under pandemic conditions. 
 
Research to support vulnerable groups needs to consider cross-cutting themes, such as: 
in the physical absence of schools and clinics, creating methods to provide connectivity 
and support; rapid innovation in mental health services  that can be remotely signposted 
and delivered, including online clinics and community support; identifying and evaluating 
means to support those at risk of abuse within the home, including online outreach; and 
swiftly providing interventions to promote mental well-being in frontline health workers. 
By identifying cross-cutting research themes, interventions to help specific 
vulnerable populations should be leveraged to help other vulnerable groups.  
 
Longer-term research priorities 
 
Health services research must reliably and iteratively inform remotely delivered mental 
health resources, such as digital clinics to efficiently manage mental health issues in an 
adaptive and flexible manner71. This requires a co-ordinating mechanism to prioritise and 
streamline efforts, working with service users to optimise signposting and delivery, as 
well as defining therapeutic targets that matter from a user perspective (e.g. loss, 
loneliness). It  requires a range of disciplines including psychology, digital science and 
social sciences72. International collaboration will ensure the necessary research skills and 
expertise. Research should harness internet-based social media and gaming using 
existing platforms, and be cognisant of a digital divide that leaves 15% of Britons 
without internet access73.  
 
Research for population-level interventions will require rapid evolution of approaches, 
starting with testing whether existing digital interventions can be repurposed, such as 
physical activity, sleep and stress management programmes, as well as targeted 
approaches for prevention and treatment of established mental health symptoms (e.g. 
anxiety and worry74). Tailoring of such universal interventions will need to be informed 
by experimental and social science, for example for loneliness befriending and physical 
activity75,76. The effectiveness of arts-based interventions also needs to be assessed77 as 
other generative activities that boost positive coping and resilience throughout society, 
from community-based activities to enhance life-skills to exercise outdoors (see lived 
experience surveys). The effectiveness of all interventions requires rigorous evaluation 
and implementation to avoid issuing a “plethora of unknown apps”78Interventions at the 
population level should be repurposed, developed and tested in a virtuous loop to create 
the necessary evidence base. 
 
(2)What is the impact of repeated media consumption about COVID-19 in 
traditional and social media on mental health and how can wellbeing be 
promoted? 
 
People seek trusted information via the media, which can provide swift, critical guidance 
regarding the pandemic. Media consumption can be adaptive and positive for mental 
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health. However, reports of infectious diseases often use risk-elevating messages, which 
can amplify public anxiety79. Social media can be a source of rapidly disseminated 
misinformation80, amplifying perceptions of risk81. Repeated media exposure to 
information about an infectious disease particularly can exacerbate stress responses, 
amplify worry and impair functioning82. Anxiety and uncertainty can drive additional 
media consumption and further distress, creating a cycle that can be difficult to break83. 
Media-fuelled distress can promote behaviours that negatively impact the healthcare 
system (e.g. visits to emergency departments, hoarding of face masks), with 
downstream mental and physical health consequences84.  
 
Immediate research priorities 
 
There is an urgent need to better understand the role of repeated media 
consumption around COVID-19 in amplifying distress and mental ill-health in 
various groups, as well as the optimal patterns of consumption to promote 
wellbeing. Research is needed to inform future approaches including strategies to: help 
individuals to stay informed by authoritative sources; prevent over-exposure to media; 
and mitigate and help manage the impact of viewing images with traumatic content.  
 
Longer-term research priorities 
 
Research should inform evidence-based guidelines for media around pandemic 
reporting, for example clearly identifying authoritative sources, limiting graphic footage 
and encouraging social media companies to flag or correct disinformation and rumours. 
Research should help develop strategies to mitigate individuals’ risk of exposure 
to misinformation and amplification of anxiety, for example by minimizing sharing 
of misinformation and strategies for managing the emotional consequences. Adaptive 
and positive uses of traditional and social media such as influencers should be 
understood and harnessed. Knowing the impact of pandemic media on various 
vulnerable groups, such as at risk children, is critical.   
 
(3)What are the best methods for promoting successful adherence to 
behavioural advice about COVID-19 whilst enabling mental wellbeing and 
minimising distress? 
  
Behavioural change – such as the three personal protective behaviours of handwashing, 
not touching the T-zone and tissue use, and social/physical distancing required to control 
the pandemic – necessitates ensuring people know what to do, are motivated to do it 
and have the skills and opportunity to enact the changed behaviours85,86. Messaging is 
key for good knowledge86, but public health messaging needs to draw on behavioural 
science if it is to be effective and avoid unintended consequences. We know that the 
more concerned people are in pandemics, the more likely they are to adhere to advice87. 
Increasing concern, however, may heighten distress, which could undermine adherence 
or exacerbate existing mental health issues. Anxiety can be fuelled by uncertainty, and 
also by fears of risk of harm to self or others. For example, feelings of paranoia88  can be 
heavily influenced by anxiety, while symptoms of OCD89 can be associated with fear of 
contagion and rigid handwashing90. Increasing people’s confidence and clarity in what 
they need to do fosters adherence to health behaviours91, and can help people to 
manage psychological distress.   
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Research on COVID-19 health messaging is urgently required to both optimise 
health behaviour change, and reduce unintended mental health issues, which 
will be required in the event of a second wave of infection. Research should 
prioritise message content, format and delivery modes and behavioural change alongside 
risk communication, and consider how this may need to vary for diverse groups. A 
virtuous cycle which tracks perceptions of and responses to public health messages 
during this pandemic will enable iterative improvements. It must be informed by mental 
health science3 to close the gap, for example, between effective behaviour messages and 
maladaptive consequences.  
 
Longer-term research priorities 
 
It will be vital to create an evidence base of lessons learned to plan for future 
pandemics. That is, detailing how to foster a rapid and coordinated response regarding 
health messaging from  governments92 and simultaneously to develop effective systems 
embedded in communities to reach out and access the most vulnerable groups in our 
society, including: 1) how to motivate and enable people to prepare psychologically and 
plan practically for possible future scenarios; and 2) how to promote people’s care and 
concern for others, fostering a sense of collective solidarity and altruism. The optimal 
messaging should be tailored (including digitally) to different social groups to connect 
diverse segments of the population to appropriate mental health information resources.  
 
Table 2. Social and population factors: the impact of COVID-19 on mental 
health 
Social and group 
factors 
Immediate action Longer term programmes 
What are the 
mental health 
consequences of 
the COVID-19 lock 
down and social 
isolation for 
vulnerable groups, 





Determine best ways of 
signposting and delivering 
mental health services for 
vulnerable groups, including 
online clinics and community 
support. Identify and 
evaluate outreach means to 
support those at risk of abuse 
within the home. 
 
Ascertain which evidence-
based interventions can be 
rapidly repurposed at scale 
for the current pandemic, and 
identify gaps requiring 
bespoke remotely-delivered 
interventions to boost 
resilience and reduce mental 
health issues.  
 
 
Based on gaps identified, 
design bespoke approaches for 
population-level interventions 
targeted at (a) prevention and 
treatment of mental health 
symptoms (e.g. anxiety) and 
(b)  boosting coping and 
resilience (e.g. exercise).  
 
Innovation for novel universal 
interventions on new 
mechanistically-based targets 
from experimental and social 
sciences (e.g. for loneliness 
befriending; gaming initiatives) 
that can help mental health. 
 
Assess the effectiveness of 
arts-based and life-skills based 
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Swiftly provide interventions 
to promote mental well-being 
in frontline health workers 
exposed to stress and trauma 
that can be delivered now 
and at scale. 
interventions and other 
generative activities including 
exercise outdoors.  
What is the impact 
of repeated media 
consumption 
about COVID-19 in 
traditional and 
social media on 
mental health and 
how can wellbeing 
be promoted? 
 
Understand the role of 
repeated media consumption 
in amplifying distress and 
anxiety, as well as optimal 
patterns of consumption for 
wellbeing.  
 
Develop strategies to prevent 
over-exposure to anxiety-
provoking media; including 
how to encourage diverse 
populations to stay informed 
by authoritative sources they 
trust. Mitigate and manage 
the impact of viewing 
distressing footage. 
 
Mitigate and manage the 







Inform evidence-based media 
policy around pandemic 
reporting (e.g. clearly identify 
authoritative sources, 




Mitigate individuals’ risk of 
misinformation (e.g. improve 
health literacy and critical 
thinking skills, minimize 
sharing of misinformation).  
 
Understand and harness 
positive uses of traditional 
media, online gaming and 
social media platforms. 
 











Understand how health 
messaging can optimise 
behaviour change, and 
reduce unintended mental 
health issues. 
 
Track perceptions of and 
responses to public health 
messages to allow iterative 
improvements, informed by 
mental health science. 
 
Synthesise evidence base of 
lessons learned for future 
pandemics, tailored to groups 
as required. 
 
Motivate and enable people to 
prepare psychologically and 
plan practically for possible 
future scenarios. 
 
Understand the facilitators and 
barriers for activities that 
promote good mental health 
(such as exercise).   
 
Promote people’s care and 
concern for others, fostering 
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Panel 2: Populations of interest, including vulnerable groups 
 
Whilst the whole population is affected by the COVID-19 pandemic different 
sections of the population will experience it differently – for example: 
• Children, young people and families: impacts of school closure particularly related 
to exposure to substance misuse, gambling, domestic violence and child 
maltreatment, lack of free school meals, accommodation and overcrowding, parental 
employment, change/disruption of social networks. 
• Older adults and those with multi-morbidities: isolation, loneliness, end of life 
care and bereavement, the digital divide.  
• People with existing mental health issues, including those with SMI: relapse, 
disruptions to services, isolation, pandemic-related information and behaviours 
exacerbating symptoms, changes in Mental Health Act. 
• Frontline healthcare workforce: fears of contamination, moral injury, disruption of 
normal supportive structures, work stress, retention, enhanced confidence/skills. 
• Excluded groups: e.g. prisoners, the homeless, refugees. 
• Society: increased health inequalities, increased foodbank use, increased social 
cohesion/communitarianism, increased race-based attacks/trauma; rural 
communities.   
• People with learning difficulties: change/disruption to support and routines, 
isolation, loneliness, risk of abuse.   
• People on low incomes: job and financial insecurity, cramped housing, limited 
access to internet and technology. 
 
 
4. Neuroscience: effects of the virus on brain health and mental health  
 
Almost nothing is yet known with certainty about the impact of SARS-CoV2 infection on 
the human nervous system. SARS-CoV2 is a zoonotic virus, and we know that about half 
of recent zoonotic epidemics have been caused by neurotropic viruses that can invade 
the central nervous system (CNS). The closely related coronaviruses responsible for the 
severe acute respiratory syndrome (SARS, 2002) and the Middle East respiratory 
syndrome (MERS, 2012) are biologically neurotropic and clinically neurotoxic, causing 
mental health and neurological disorders93–95. SARS-CoV2 is genetically almost identical 
to the SARS-CoV coronavirus, and likely to share its neurotropism and neurotoxicity. 
 
Neurological symptoms of COVID-19 infection are common, diverse, and often severe. In 
a retrospective study of 214 patients in Wuhan, China, 36% had CNS symptoms or 
disorders and the subgroup of 88 patients with severe respiratory disease had 
significantly increased frequency of CNS problems (45%)96. The problems reported 
include dizziness, headache, loss of smell (anosmia), loss of taste (ageusia), muscle pain 
and weakness, impaired consciousness, and cerebrovascular complications. Similar 
reports have begun to emerge from Italy97. Some of these acute neurological 
presentations could reflect systemic aspects of infection, such as disseminated 
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intravascular coagulation causing strokes, or intense inflammation and hypoxia causing 
delirium.  
 
SARS-CoV2 infection of the brain could be a major contributor to the core medical 
syndrome of respiratory distress and failure in COVID-19 patients98. Viral infection of the 
lung alveoli is the immediate cause of SARS; but viral infection of the brain stem nuclei 
could disrupt the normal rhythms and homeostatic control of respiration. This idea needs 
to be rapidly tested98: if brain stem infection does contribute to SARS-severity and ICU-
dependency, that could be directly relevant to the immediate COVID-19 crisis in the NHS 
and other healthcare systems.       
 
In the longer term, SARS-CoV2 could persistently replicate and proliferate in the brain 
with direct neurotoxic effects and immune-mediated neurotoxic effects. The Spanish flu 
epidemic of 1918-19 was linked to a spike in incidence of post-encephalitic Parkinsonism 
99. Currently, it is not known if SARS-CoV2 infection of the brain could cause mental 
health or neurodegenerative disorders, immediately or years after the acute respiratory 
phase of COVID-19 has passed; but immediate action is needed to build the research 
capacity to test these potentially important biological causes of COVID-19 related mental 
illness.  
 
Table 3. Neuroscience: effects of the virus on brain health and mental health 
Immediate actions Strategic research programmes 
Build a neuro-psychological database 
on UK COVID-19 cases (standardised, 
longitudinally repeated, data at scale; 
clinically and geographically inclusive)  
Understand how SARS-CoV2 might 
enter and propagate through the brain 
and how the immune response to 
SARS-CoV2 infection contributes to 
mental health and neurological 
symptoms  
 
Investigate the long-term relationship 
between SARS-CoV2 infection and post 
infective fatigue or depressive 
syndromes 
 
Validate clinical biomarkers of SARS-




Expand facilities for SARS-CoV2 tissue 
handling 
Develop interventions to interrupt or 
prevent the adverse biological impacts 
of COVID-19 on brain function and 





A neuro-psychological database on COVID 19 cases needs to bring together 
standardised, longitudinally repeated, data at scale both from the clinic for those 
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needing hospital treatment and by online assessments for patients in isolation at home. 
Following the progression of clinical symptoms over time will be key to understanding 
and predicting the effects of infection on the CNS.  
 
Facilities for SARS-CoV2 tissue handling need to be expanded to examine human 
brain tissue post mortem, crucial to understanding the neurotropic and neurotoxic 
properties of the virus. Facilities equipped to safely handle human (or animal) brain 
tissue infected with SARS-CoV2 are currently very limited. We recommend building 
pathology and molecular neuroscience networks to enable brain and other tissue to be 
collected at autopsy and examined for viral infection and damage. This will require 
protocols for tissue collection and examination in appropriate laboratory facilities to 
protect researchers and other staff at all times. 
 
Longer term research priorities 
 
Mechanisms by which SARS-CoV2 might enter the brain need to be understood. 
There are two likely pathways: neuronal and vascular100. The neuronal pathway used by 
other coronaviruses101,102 is to invade a specialist sensory receptor in peripheral tissue, 
travel by axonal transport systems to the brain stem, and propagate between neurons 
by trans-synaptic mechanisms. We need to know if SARS-CoV2 can follow the same path 
to infect the human brain and whether it invades nerve cells by “hijacking” angiotension 
converting enzyme 2 (ACE2)103–105, despite neurons expressing low levels of ACE2106–108. 
SARS-CoV2 could invade the brain from the blood if circulating particles of the virus were 
transported across the blood-brain barrier by binding to ACE2 receptors expressed by 
endothelial cells108, or if infected leucocytes could carry the virus with them as they 
migrate into the tissues as part of the immune response to infection109. We also need to 
better understand how the intense systemic immune response to SARS-CoV2 infection 
impacts mental health and neurological symptoms96,110,111 as well as the mechanisms of 
immune clearance of SARS-CoV2112,113.    
 
Post infectious fatigue and depressive syndromes have been associated with epidemics, 
and it seems likely that the same will be true of the current pandemic. Longitudinal 
studies, especially if commenced before or soon after the start of the current pandemic, 
will be crucial in establishing the often complex biological pathways between infection 
and mental health outcomes114–116.  
 
Candidate biomarkers need to be evaluated to measure SARS-CoV2 infection of the 
human brain and brain stem in living patients, including magnetic resonance imaging 
(MRI  – e.g. T2 FLAIR to assess possible inflammation), cerebral blood flow imaging (to 
measure vascular and metabolic effects), and magnetic resonance spectroscopy to 
measure neurochemicals and metabolites. 7 Tesla MRI has sufficient spatial resolution to 
measure functional connectivity between subcortical structures that constitute networks 
for respiratory control and distress117. Other methods could include sampling CSF or 
positron emission tomography (PET) to measure brain inflammation; self-reporting or 
behavioural testing of smell, taste and other cranial or vagal sensory functions; 
electrophysiological methods to measure brain stem function; and computerised tests of 
cognitive and emotional processing.  
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Informed by greater understanding of SARS-CoV2 infection on the nervous system, as 
well as more accurate biomarkers of brain infection in COVID-19 patients, 
interventions need to be developed to interrupt or prevent the adverse 
biological impacts of COVID-19 on brain function and mental health. Potential 
drug targets include putative mechanisms for neuronal invasion, inter-neuronal 
propagation, and immune clearance by SARS-CoV2. Biological and clinical validation of 
these or other targets would enable experimental medicine studies or early clinical trials 
of repurposed drugs. For example, ACE2 inhibitors already licensed for treatment of 
hypertension, or the serine protease TMPRSS2118, which co-operates with ACE2 to 
facilitate viral entry into cells, and is blocked by a licensed drug for reflux oesophagitis, 
have already been advocated as repurposable drugs. There are many other potential 
candidates for drug repurposing119, which could be a faster route to effective treatment 
for CNS infection than development of entirely new drugs or vaccines. Partnerships 
between researchers in academia and industry will be vital. 
 
 
5. Infrastructure and opportunities  
 
Many of the immediate priorities are for surveillance of general and specific populations 
for health impacts, ranging from health behaviours, psychological symptoms, 
neuropsychiatric disorders and mortality including, but not limited to, suicide. The other 
immediate priority is to assemble cohorts to determine longer term outcomes and 
provide a resource for nesting intervention studies, as well as a resource of interventions 
to monitor their effectiveness. We recommend three main routes, which we describe in 
more detail below. For each of these routes, there is a need to coordinate existing 
research infrastructure  through shared protocols, research measures and data 
assets, as well as to uphold the highest standards of scientific and ethical review. We 
urge the mental health science community to combine agility in initiating new or 
adapting existing research with collective scrutiny and collaboration.  
 
First, administrative data assets principally derived from existing electronic health 
records, with systems in place to interrogate these for research purposes, provide a 
means of identifying health impacts at scale. Health Data Research UK is coordinating 
national efforts. Examples include the Clinical Practice Research Database120 (CPRD) and 
similar primary care databases; the Clinical Record Interactive Search121 (CRIS) and 
related systems for the interrogation of mental health records; and for general hospital 
settings, CogStack122 which provides near real-time information from health records, for 
example to provide feedback on neurological consequences of severe COVID-19123. 
These systems should be linked between mental health, acute medical and community 
health service providers to identify patterns and trends both in clinical populations and in 
individuals with confirmed or suspected COVID-19.  
 
Second, surveillance through recruitment platforms and existing cohorts has the 
benefit of embedding research on COVID-19 into studies where participants’ mental or 
cognitive health has previously been ascertained. Existing cohorts or data platforms that 
can be rapidly deployed for COVID-19 research are likely to be particularly valuable.  
Examples include the NIHR National Bioresource, a platform which already includes 
clinical data on participants and DNA, and could be deployed for rapid characterization of 
mental health and neurological symptoms. UK Biobank has successfully conducted a 
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web-based mental health survey on 160,000 individuals, and the ongoing neuroimaging 
studies of 100,000 individuals provide an ideal opportunity to image the impact of SARS-
Cov-2 infection on the brain/brainstem via a pre- to post-imaging comparison.  
 
Third, novel population based studies on mental health and COVID-19 should be 
established, both using appropriate epidemiologically robust survey methodology for the 
whole population and specific groups of particular interest (e.g. children and young 
people, frontline staff in health and social care, and people who have survived severe 
COVID-19). Priority should be given to assembling representative populations using 
explicit sampling frames. Finally, many other disciplines will be establishing similar 
studies and it is vital that the ascertainment of mental health should be embedded 
wherever possible.  
 
Whether using established or new cohorts, priority should be given to methods 
which can ascertain COVID-19 status, symptoms and behaviours in as close to 
real time as possible providing a dynamic picture of change in illness status, social 
circumstances and behaviours. Questions on COVID-19 and mental health symptoms 
and social stressors can readily be pushed out via smartphones. Passive data from 
smartphones can also give high temporal resolution to behaviours related to the 
pandemic. Cohorts should gain permissions for record linkage including serological status 
when mass testing becomes available, and consent for recruitment into nested sub-
studies including randomised trials of interventions.   
 
Patient and public involvement in research is a critical underpinning component to 
research. Given that the entire population has lived experience of the COVID-19 
pandemic, researchers will need to be particularly mindful of consulting and collaborating 
with patient and public groups  that reflect the diverse groups being studied in 
developing protocols, conducting research and interpreting results (Panel 3).   
 
Panel 3: Principles of good research practice in COVID-19 research 
 
Study design: Researchers must continue to articulate the patient group or population 
and the research question under study. A priori research questions are crucial. Sample 
size, sources of bias and study design need to be carefully considered and appropriate to 
the research questions.  
 
Ethics: Research on human participants should maintain high standards of ethical 
practice, including seeking research ethics committee approval124. Committees now have 
fast-track procedures to expedite study start up.  Ethical considerations for conducting 
COVID-19 related research have been published125,126. 
 
Vulnerable groups: Researchers should recognise the capacity of the pandemic to 
exacerbate health inequalities within populations, particularly affecting people with 
established mental health issues (including SMI) and physical disability, those with 
precarious or no employment or housing, or other forms of social inequality, such as 
digital poverty40. 
 
Involvement of patients, people with lived experience and the public: 
Researchers should continue to engage and involve their ultimate consumers, patients, 
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people with lived experience, the public and service providers, in mutually setting 
research questions, testing the acceptability of protocols and questionnaires, and the 
interpretation of results. Researchers should ensure that they discuss their research 
findings with participants. 
 
 
Harmonised data and measures: There is an obvious need for researchers to use and 
share, where possible, full study protocols and measures. This will facilitate comparisons 
between data and projects. 
 
Open science, reproducibility and data sharing: The urgency of the research effort 
should be a strong driver for the principle of reproducible science. The ready availability 
of analysis code and data is critical to verifying findings and the rapid peer review of 
study protocols127, prior to data collection, minimises waste and ensures conclusions are 
empirically sound. 
 
Interdisciplinary working: The challenge of COVID-19 pandemic requires imaginative 
collaborations between disciplines, including but not limited to psychology, psychiatry, 
neuroscience, virology, intensive care units, and respiratory medicine, among many 
others. Previous experience with epidemics has shown the “essential role that the 
humanities and social sciences play in information, reduction of fear and stigma, 
prevention, screening, treatment adherence, and control policies”128.  
 
Collaboration and coordination: Where possible, research protocols should be 
deployed at scale harnessing existing research infrastructures including the Clinical 
Research Networks, Biomedical Research Centres, Mental Health Translational Research 
Collaboration, MQ Data Science group, charities, service user groups and professional 
bodies. To avoid waste and protect against participant fatigue, it is vital that there is 
national coordination across research groups. International collaboration and a global 
perspective will be beneficial. 
 
 
6. Call for action  
 
Multidisciplinary mental health science research must be central to the 
international response to the current pandemic, given the potential impacts on 
individual and population mental health and its potential impact on the brain function of 
some of those affected by COVID-19. There are important immediate insights to be 
gained, which could provide evidence-based guidance on responding to this pandemic, 
as well as how to promote mental health and wellbeing and safeguard the brain should 
future waves of infection re-emerge (see Panel 4).  
 
The research priorities across the social, psychological and neuroscientific aspects of this 
pandemic should be coordinated at a national and international level. We urge UK 
research funding agencies to work with researchers, people with lived 
experience and others to establish a high level co-ordination group to ensure 
that the mental health science research priorities are addressed swiftly, and 
that a firm base is established for long term studies. We need rigorous, peer-
reviewed, ethically-approved research co-developed with people with lived experience 
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that can be translated into effective interventions, rather than the current uncoordinated 
approach with a plethora of underpowered studies and surveys. 
 
The immediate priority is collecting high quality data on the mental health and 
psychological impacts of the COVID-19 pandemic across the whole population and 
vulnerable groups, and on brain function, cognition and mental health for COVID-19 
patients at all clinical stages of infection and illness. These datasets must be brought 
together under a national data portal for rapid access and use.     
 
There is an urgent need for the discovery, evaluation and refinement of 
mechanistically-driven interventions to address the psychological, social and 
neuroscientific aspects of this pandemic. This includes bespoke psychological 
interventions to boost resilience and minimize mental health risks across society and in 
vulnerable groups, and experimental medicine studies to validate clinical biomarkers and 
repurpose new treatments for the potentially neurotoxic effects of the virus. There is an 
urgent need for research to address the impact of repeated pandemic related media 
consumption and to optimise health messaging around COVID-19. Rising to this 
challenge will require integration across disciplines and sectors, including 
industry and health and social care. 
 
New funding will be required to meet these priorities, but it can be efficiently 
leveraged by the UK’s world-leading neuroscience and mental health research 
infrastructure. The UK must connect with international funders and researchers to 
support a global response to the mental health and neurological challenges of this 
pandemic. These are challenging times, but there is a tremendous opportunity for 
mental health science to serve society and benefit medicine in the long term. 
 
Panel 4: Rapid learnings to apply to future infection waves or pandemics 
 
The outputs of immediate research could help inform responses to future infection waves 
of pandemics, for example by identifying: 
• Mechanisms to support vulnerable groups under pandemic conditions – such as front 
line health and social care staff and those with pre-existing mental health issues, 
young people and older adults – including coping strategies and preventative 
interventions.   
• Interventions that reduce mental health issues and boost resilience, including those 
that can be repurposed. 
• Solutions to the impact of repeated media consumption about COVID-19 on the 
mental wellbeing of the nation to help individuals stay informed by authoritative 
sources while preventing over-exposure and mitigating the impact of viewing 
traumatic content. 
• Methods for promoting more successful adherence to behavioural advice about 




EB, EAH, MH, RCOC, VHP, IT and SW contributed to the literature review, 
conceptualisation, design and interpretation of surveys, and writing and editing of the 
manuscript as part of the core advisory group. CC contributed to and coordinated the 
The Lancet Psychiatry Personal View: DRAFT 19 FOR RE-SUBMISSION 
07 April 2020 
21 
 
writing and editing of the manuscript. KC analysed the qualitative data gathered via the 
stakeholder survey. LA, CB, HC, IE, TF, AJ, IM, SM, AKP, RS, RCS, CMW and LY 
contributed to the drafting and formulation of the manuscript as part of the expert 
advisory group. TK, KK and AS contributed the drafting and formulation of the 
manuscript as part of the expert advisory group and by including lived-experience 
expertise. All authors approved the final version for submission. 
 
Declaration of interest 
CB reports grants and personal fees from Acadia pharmaceutical company and Lundbeck, 
personal fees from Roche, Otsuka, Biogen, Eli Lilly, Novo Nordisk, AARP and Exciva, and 
grants from Synexus, outside the submitted work. 
EAH reports grants from The Lupina Foundation, The OAK Foundation, The Swedish 
Research Council, outside the submitted work. EAH reports her primary affiliation is 
Department of Psychology, Uppsala University, Sweden and is also a professor at 
Division of Psychology, Department for Clinical Neuroscience, Karolinska Institutet, 
Stockholm, Sweden. EAH reports serving on the board of trustees of the charity MQ: 
Transforming Mental Health (UK) as chair of the research committee. She receives no 
remuneration for these roles. EAH reports serving on the Editorial Advisory Board of The 
Lancet Psychiatry, and is an Associate Editor of Behavior Research and Therapy. She is 
the F1000 prime: Clinical Psychology and Psychopathology Section Head and is on the 
Editorial Board of following journals: Current Opinion in Psychology, Clinical Psychology 
in Europe, and Cognitive Behaviour Therapy. EAH receives book royalties from Oxford 
University Press (Imagery and Cognitive Therapy) and Guilford Press (Imagery-Based 
Cognitive Therapy for Bipolar Disorder and Mood Instability). She receives occasional 
fees from clinical workshops and conference keynotes. She receives occasional 
consultancy fees from SBU: Statens beredning för medicinsk och social utvärdering 
(Swedish agency for health technology assessment and assessment of social services), 
Sweden. 
AKP has been financially supported by UK taxpayers, the UK's Economic and Social 
Research Council, the British Academy, the Diana Award, the John Fell Fund, the 
Leverhulme Trust, Barnardo's UK, and the Huo Family Foundation in the past five years. 
As part of science communication and policy outreach activities, he has served in an 
unpaid advisory capacity to the Organization for Economic Co-operation and 
Development, Facebook Inc., Google Inc., and the ParentZone. 
IT is a Trustee of MQ, which is a mental health charity dedicated to raise funds to 
support research into mental health. She is also on the Council for the Medical Research 
Council of the United Kingdom. 
MH reports grants from Innovative Medicines Intiative, outside the submitted work. 
CC reports that Academy of Medical Science staff, including herself, and activity costs for 
this work were supported by a core grant the Academy of Medical Sciences receives 
annually from the Government Department for Business, Energy & Industrial Strategy 
for policy, communications and public engagement. She also reports that her husband is 
an employee of Otsuka Pharmaceutical Europe Limited and is a Trustee of The McPin 
Foundation. 
All other authors declare no competing interests.  
 
Funding source 
LA is the Mental Health Leadership Fellow for the Economic and Social Research Council. 
The Lancet Psychiatry Personal View: DRAFT 19 FOR RE-SUBMISSION 
07 April 2020 
22 
 
EB is a National Institute for Health Research (NIHR) Senior Investigator. This paper 
represents independent research part-funded by the National Institute for Health 
Research (NIHR) Biomedical Research Centre at Cambridge University Hospital NHS 
Trust and the University of Cambridge. The views expressed are those of the author(s) 
and not necessarily those of the NHS, the NIHR or the Department of Health and Social 
Care. 
CC indicated that Academy of Medical Science staff, including herself, and activity costs 
for this work were supported by a core grant the Academy of Medical Sciences receives 
annually from the Government Department for Business, Energy & Industrial Strategy 
(BEIS) for policy, communications and public engagement. 
MH is funded by the National Institute of Health Research Biomedical Research Centre at 
the Maudsley and a National Institute of Health Research Senior Investigator Award. This 
paper represents independent research part-funded by the National Institute for Health 
Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS 
Foundation Trust and King’s College London. The views expressed are those of the 
author(s) and not necessarily those of the NHS, the NIHR or the Department of Health 
and Social Care. NIHR were not involved in any aspect of the publication and had no role 
in the decision to submit.  
AKP received funding from the Huo Family Foundation. 
RS indicated that all research at Great Ormond Street Hospital NHS Foundation Trust 
and UCL Great Ormond Street Institute of Child Health is made possible by the NIHR 
Great Ormond Street Hospital Biomedical Research Centre. The views expressed are 
those of the author(s) and not necessarily those of the NHS, the NIHR or the 
Department of Health and Social Care. 
LY is an NIHR Senior Investigator and her research programme is partly supported by 
NIHR Applied Research Collaboration (ARC)-West, NIHR Health Protection Research Unit 
(HPRU) for Behavioural Science and Evaluation, and the NIHR Southampton Biomedical 
Research Centre (BRC). 
The funding for TK’s salary came solely from his employer, The McPin Foundation. 
The views expressed are the views of the authors alone and do not necessarily represent 
the views of their organisations or funding sources. 
 
Acknowledgements 
We are grateful to all staff at the Academy of Medical Sciences and MQ for their work in 
coordinating and supporting this project’s secretariat and communications. Special 
thanks to Rachel Quinn, Nick Hillier, Helen Munn, Neil Balmer, Angeliki Yiangou, Fern 
Brookes, Holly Rogers, Claire Bithell, Naomi Clarke, Melanie Etherton, Tom Livermore, 
Dylan Williams and Daisy Armitage. We also extend our sincere thanks to Katie White, 
Carolin Oetzmann, Valeria de Angel and Dr Sumithra Velupillai at King’s College London 
for their tremendous efforts in data analysis, and Dr Beau Gamble at Uppsala University 
and Dr Seonaid Cleare at University of Glasgow for their support with referencing. We 
are also grateful to the team at Ipsos MORI for their work on the online omnibus. Special 
thanks also to everyone who participated in the MQ and Ipsos MORI surveys for sharing 
their views and personal experiences during challenging times – we are hugely grateful 
to them for their openness and honesty about mental health and wellbeing. We are 




The Lancet Psychiatry Personal View: DRAFT 19 FOR RE-SUBMISSION 







References   
1 McManus S, Bebbington P, Jenkins R, Brugha T. Mental health and wellbeing in 
England: Adult Psychiatric Morbidity Survey 2014. Leeds, 2016. 
2 Ford T, Vizard T, Sadler K, et al. Data Resource Profile: The Mental Health of 
Children and Young People Surveys (MHCYP). Int J Epidemiol 2020. 
DOI:10.1093/ije/dyz259. 
3 Holmes EA, Craske MG, Graybiel AM. Psychological treatments: A call for mental-
health science. Nature 2014; 511: 287–9. 
4 Ipsos MORI. Covid-19 and mental wellbeing. https://www.ipsos.com/ipsos-
mori/en-uk/Covid-19-and-mental-wellbeing (accessed April 7, 2020). 




(accessed April 5, 2020). 
6 Qiu J, Shen B, Zhao M, Wang Z, Xie B, Xu Y. A nationwide survey of psychological 
distress among Chinese people in the COVID-19 epidemic: implications and policy 
recommendations. Gen Psychiatry 2020; 33: e100213. 
7 Lai J, Ma S, Wang Y, et al. Factors associated with mental health outcomes among 
health care workers exposed to coronavirus disease 2019. JAMA Netw Open 2020; 
3: e203976. 
8 Wang C, Pan R, Wan X, et al. Immediate psychological responses and associated 
factors during the initial stage of the 2019 coronavirus disease (COVID-19) 
epidemic among the general population in China. Int J Environ Res Public Health 
2020; 17: 1–25. 
9 Liu S, Yang L, Zhang C, et al. Online mental health services in China during the 
COVID-19 outbreak. Lancet Psychiatry 2020; 7: e17–8. 
10 Bo H-X, Li W, Yang Y, et al. Posttraumatic stress symptoms and attitude toward 
crisis mental health services among clinically stable patients with COVID-19 in 
China (accepted). Psychol Med 2020; published online March 27. 
DOI:10.1017/S0033291720000999. 
11 Xiao H, Zhang Y, Kong D, Li S, Yang N. The effects of social support on sleep 
quality of medical staff treating patients with coronavirus disease 2019 (COVID-
19) in January and February 2020 in China. Med Sci Monit 2020; 26: e923549. 
12 Li S, Wang Y, Xue J, Zhao N, Zhu T. The Impact of COVID-19 Epidemic Declaration 
on Psychological Consequences: A Study on Active Weibo Users. Int J Environ Res 
Public Health 2020; 17: 2032. 
13 Brooks SK, Webster RK, Smith LE, et al. The psychological impact of quarantine 
and how to reduce it: rapid review of the evidence. Lancet 2020; 395: 912–20. 
14 Li Z, Ge J, Yang M, et al. Vicarious traumatization in the general public, members, 
and non-members of medical teams aiding in COVID-19 control. Brain Behav 
Immun 2020; published online March 10. DOI:10.1016/j.bbi.2020.03.007. 
The Lancet Psychiatry Personal View: DRAFT 19 FOR RE-SUBMISSION 
07 April 2020 
24 
 
15 Huang JZ, Han MF, Luo TD, Ren AK, Zhou XP. Mental health survey of 230 medical 
staff in a tertiary infectious disease hospital for COVID-19. Zhonghua Lao Dong 
Wei Sheng Zhi Ye Bing Za Zhi 2020; 38: E001. 
16 Gunnell D, Appleby L, Arensman E, et al. Suicide risk and prevention during the 
COVID19 pandemic (submitted). Lancet Psychiatry. 
17 Yip PS. PSF, Cheung Y. T, Chau P. H, Law Y. W. The impact of epidemic outbreak: 
the case of severe acute respiratory syndrome (SARS) and suicide among older 
adults in Hong Kong. Crisis 2010; 31: 86–92. 
18 Tsang HW, Scudds RJ, Chan EY. Psychosocial impact of SARS. Emerg Infect Dis 
2004; 10: 1326–7. 
19 Nickell LA, Crighton EJ, Tracy CS, et al. Psychosocial effects of SARS on hospital 
staff: survey of a large tertiary care institution. CMAJ 2004; 170: 793–8. 
20 O’Connor RC, Nock MK. The psychology of suicidal behaviour. Lancet Psychiatry 
2014; 1: 73–85. 
21 John A, Glendenning AC, Marchant A, et al. Self-harm, suicidal behaviours, and 
cyberbullying in children and young people: Systematic review. J Med Internet Res 
2018; 20: e129. 
22 Turecki G, Brent DA, Gunnell D, et al. Suicide and suicide risk. Nat Rev Dis Prim 
2019; 5: 1–22. 
23 Elovainio M, Hakulinen C, Pulkki-Råback L, et al. Contribution of risk factors to 
excess mortality in isolated and lonely individuals: an analysis of data from the UK 
Biobank cohort study. Lancet Public Heal 2017; 2: e260–6. 
24 Matthews T, Danese A, Caspi A, et al. Lonely young adults in modern Britain: 
Findings from an epidemiological cohort study. Psychol Med 2018; 49: 268–77. 
25 O’Connor RC, Kirtley OJ. The integrated motivational-volitional model of suicidal 
behaviour. Philos Trans R Soc B Biol Sci 2018; 373: 20170268. 
26 Stack S. Suicide: media impacts in war and peace, 1910-1920. Suicide Life‐
Threatening Behav 1988; 18: 342–57. 
27 Barr B, Taylor-Robinson D, Scott-Samuel A, McKee M, Stuckler D. Suicides 
associated with the 2008-10 economic recession in England: Time trend analysis. 
BMJ 2012; 345: 1–7. 
28 Frasquilho D, Matos MG, Salonna F, et al. Mental health outcomes in times of 
economic recession: A systematic literature review Health behavior, health 
promotion and society. BMC Public Health 2016; 16: 1–40. 
29 Prieto L, Sacristán JA. Problems and solutions in calculating quality-adjusted life 
years (QALYs). Health Qual Life Outcomes 2003; 1: 1–8. 
30 Holmes EA, Ghaderi A, Harmer CJ, et al. The Lancet Psychiatry Commission on 
psychological treatments research in tomorrow’s science. The Lancet Psychiatry 
2018; 5: 237–86. 
31 Kazdin AE. Mediators and Mechanisms of Change in Psychotherapy Research. Annu 
Rev Clin Psychol 2007; 3: 1–27. 
32 Carl E, Witcraft SM, Kauffman BY, et al. Psychological and pharmacological 
treatments for generalized anxiety disorder (GAD): a meta-analysis of randomized 
controlled trials. Cogn Behav Ther 2020; 49: 1–21. 
33 Hawton K, Witt KG, Salisbury TLT, et al. Psychosocial interventions following self-
The Lancet Psychiatry Personal View: DRAFT 19 FOR RE-SUBMISSION 
07 April 2020 
25 
 
harm in adults: a systematic review and meta-analysis. The Lancet Psychiatry 
2016; 3: 740–50. 
34 Cuijpers P, Cristea IA, Karyotaki E, Reijnders M, Hollon SD. Component studies of 
psychological treatments of adult depression: A systematic review and meta-
analysis. Psychother Res 2019; 29: 15–29. 
35 Spinhoven P, Cuijpers P, Hollon S. Cognitive-behavioural therapy and personalized 
treatment:An introduction to the special issue. Behav Res Ther 2020. 
DOI:10.1016/j.brat.2020.103595. 
36 Torok M, Han J, Baker S, et al. Suicide prevention using self-guided digital 
interventions: a systematic review and meta-analysis of randomised controlled 
trials. Lancet Digit Heal 2020; 2: e25–36. 
37 Garrido S, Millington C, Cheers D, et al. What works and what doesn’t work? A 
systematic review of digital mental health interventions for depression and anxiety 
in young people. Front Psychiatry 2019; 10: 19. 
38 Lattie EG, Adkins EC, Winquist N, Stiles-Shields C, Wafford QE, Graham AK. Digital 
mental health interventions for depression, anxiety and enhancement of 
psychological well-being among college students: Systematic review. J Med 
Internet Res 2019; 21: e12869. 
39 National Confidential Inquiry into Suicide and Homicide by People with Mental 
Illness. 2017. www.hqip.org.www.bbmh.manchester.ac.uk/cmhs (accessed April 
1, 2020). 
40 Greer B, Robotham D, Simblett S, Curtis H, Griffiths H, Wykes T. Digital Exclusion 
Among Mental Health Service Users: Qualitative Investigation. J Med Internet Res 
2019; 21: e11696. 
41 Huckvale K, Venkatesh S, Christensen H. Toward clinical digital phenotyping: a 
timely opportunity to consider purpose, quality, and safety. npj Digit Med 2019; 
published online Sept 6. DOI:10.1038/s41746-019-0166-1. 
42 O’Connor RC, Portzky G. Looking to the future: a synthesis of new developments 
and challenges in suicide research and prevention. Front Psychol 2018; 9: 1–14. 
43 Lazarus RS, Folkman S. Stress, appraisal, and coping. Springer Publishing 
Company, 1984. 
44 Folkman S. Stress, Health, and Coping: Synthesis, Commentary, and Future 
Directions. In: Folkman S, ed. The Oxford Handbook of Stress, Health, and 
Coping. Oxford University Press, 2010. 
https://doi.org/10.1093/oxfordhb/9780195375343.013.0022 (accessed March 30, 
2020). 
45 Folkman S, Moskowitz JT. Coping: pitfalls and promise. Annu Rev Psychol 2004; 
55: 745–74. 
46 Sehmi R, Maughan B, Matthews T, Arseneault L. No man is an island: social 
resources, stress and mental health at mid-life. Br J Psychiatry 2019. 
DOI:10.1192/bjp.2019.25. 
47 Brooks SK, Webster RK, Smith LE, et al. The psychological impact of quarantine 
and how to reduce it: rapid review of the evidence. Lancet 2020; 395: 912–20. 
48 Duan L, Zhu G. Psychological interventions for people affected by the COVID-19 
epidemic. Lancet 2020; 7: 300–2. 
49 Alvaro PK, Roberts RM, Harris JK. A systematic review assessing bidirectionality 
The Lancet Psychiatry Personal View: DRAFT 19 FOR RE-SUBMISSION 
07 April 2020 
26 
 
between sleep disturbances, anxiety, and depression. Sleep 2013; 36: 1059–68. 
50 Connor DBO, Gartland N, Connor RCO. Stress, cortisol and suicide risk (in press). 
Int Rev Neurobiol 2020. DOI:10.1016/bs.irn.2019.11.006. 
51 Dawson KS, Bryant RA, Harper M, et al. Problem Management Plus (PM+): a WHO 
transdiagnostic psychological intervention for common mental health problems. 
World Psychiatry 2015; 14: 354–7. 
52 Hogan BE, Linden W, Najarian B. Social support interventions: do they work? Clin 
Psychol Rev 2002; 22: 381–440. 
53 Ashdown-Franks G, Firth J, Carney R, et al. Exercise as medicine for mental and 
substance use disorders: A meta-review of the benefits for neuropsychiatric and 
cognitive outcomes. Sport Med 2020; 50: 151–70. 
54 Solomonov N, Bress JN, Sirey JA, et al. Engagement in socially and interpersonally 
rewarding activities as a predictor of outcome in “Engage” behavioral activation 
therapy for late-life depression. Am J Geriatr Psychiatry 2019; 27: 571–8. 
55 Meunier S, Roberge C, Coulombe S, Houle J. Feeling better at work! Mental health 
self-management strategies for workers with depressive and anxiety symptoms. J 
Affect Disord 2019; 254: 7–14. 
56 Taubman D.S, Parikh S.V, Christensen H, Scott J. Using school-based 
interventions for depression education and prevention. In: Javed A, Fountoulakis 
K, eds. Advances in Psychiatry. Springer, 2019: 1–32. 
57 Wasserman D, Rutger  van der G, Wise J. Terms ‘physical distancing’ and 
‘emotional closeness’ should be used and not ‘social distancing’ when defeating 
the Covid-19 pandemic. Sci. eLetters. 2020. 
https://science.sciencemag.org/content/367/6484/1282/tab-e-letters (accessed 
April 3, 2020). 
58 Swinburn BA, Kraak VI, Allender S, et al. The Global Syndemic of Obesity, 
Undernutrition, and Climate Change: The Lancet Commission report. Lancet 2019; 
393: 791–846. 
59 Rubin GJ, Potts HWW, Michie S. The impact of communications about swine flu 
(influenza A HINIv) on public responses to the outbreak: Results from 36 national 
telephone surveys in the UK. Health Technol Assess (Rockv) 2010; 14: 183–266. 
60 Lau JTF, Griffiths S, Choi KC, Tsui HY. Avoidance behaviors and negative 
psychological responses in the general population in the initial stage of the H1N1 
pandemic in Hong Kong. BMC Infect Dis 2010; 10: 1–13. 
61 Wang J, Lloyd-Evans B, Giacco D, et al. Social isolation in mental health: a 
conceptual and methodological review. Soc Psychiatry Psychiatr Epidemiol 2017; 
52: 1451–61. 
62 Cacioppo JT, Hughes ME, Waite LJ, Hawkley LC, Thisted RA. Loneliness as a 
specific risk factor for depressive symptoms: Cross-sectional and longitudinal 
analyses. Psychol Aging 2006; 21: 140–51. 
63 Lv Y, Zhang Z, Zeng W, Li J, Wang X, Luo L. Anxiety and depression survey of 
Chinese medical staff before and during COVID-19 defense. Lancet Prepr 2020; 
published online March 30. DOI:10.2139/ssrn.3551350. 
64 Collishaw S. Annual Research Review: Secular trends in child and adolescent 
mental health. J Child Psychol Psychiatry 2015; 56: 370–93. 
65 Sellers R, Warne N, Pickles A, Maughan B, Thapar A, Collishaw S. Cross‐cohort 
The Lancet Psychiatry Personal View: DRAFT 19 FOR RE-SUBMISSION 
07 April 2020 
27 
 
change in adolescent outcomes for children with mental health problems. J Child 
Psychol Psychiatry 2019; 60: 813–21. 
66 Fazel M, Karunakara U, Newnham EA. Detention, denial, and death: migration 
hazards for refugee children. Lancet Glob Heal 2014; 2: e313–4. 
67 Schoneveld EA, Lichtwarck-Aschoff A, Granic I. Preventing childhood anxiety 
disorders: is an applied game as effective as a cognitive behavioral therapy-based 
program? Prev Sci 2018; 19: 220–32. 
68 Armitage R, Nellums LB. COVID-19 and the consequences of isolating the elderly. 
Lancet Public Heal 2020; published online March 19. DOI:10.1016/S2468-
2667(20)30061-X. 
69 Robotham D, Sweeney A, Perôt C. Survivors’ priority themes and questions for 
research. 2019. 
https://www.vamhn.co.uk/uploads/1/2/2/7/122741688/consultation_report_on_w
ebsite.pdf (accessed March 30, 2020). 
70 Sweeney, A, Beresford, P, Nettle, M, Faulkner, A, Rose D. This Is Survivor 
Research. PCCS Books, 2009 
https://www.researchgate.net/publication/257606229_This_Is_Survivor_Research 
(accessed March 30, 2020). 
71 Wind TR, Rijkeboer M, Andersson G, Riper H. The COVID-19 pandemic: The ‘black 
swan’ for mental health care and a turning point for e-health. Internet Interv 
2020; published online March 19. DOI:10.1016/j.invent.2020.100317. 
72 Milton AL, Holmes EA. Of mice and mental health: facilitating dialogue and seeing 
further. Philos Trans R Soc B 2018; 373: 20170022. 
73 Blank G, Dutton WH, Lefkowitz J. OxIS 2019: Digital Divides in Britain are 
Narrowing but Deepening. 2020. https://ssrn.com/abstract=3522083 (accessed 
April 4, 2020). 
74 Hirsch CR, Krahé C, Whyte J, et al. Interpretation Training to Target Repetitive 
Negative Thinking in Generalized Anxiety Disorder and Depression. J Consult Clin 
Psychol 2018; 86: 1017–30. 
75 Holt-Lunstad J, Robles TF, Sbarra DA, Julianne Holt-Lunstad N. Advancing Social 
Connection as a Public Health Priority in the United States. Am Psychol 2017; 72: 
517–30. 
76 Agency for Healthcare Research and Quality. Addressing social isolation To 
improve the health of older adults: A rapid review. 2019 www.ahrq.gov (accessed 
March 30, 2020). 
77 Fancourt D, Finn S. What is the evidence on the role of the arts in improving 
health and well-being? A scoping review. Copenhagen: WHO Regional Office for 
Europe, 2019. 
78 Anthes E. Pocket psychiatry: mobile mental-health apps have exploded onto the 
market, but few have been thoroughly tested. Nature 2016; 532: 20–3. 
79 Sell TK, Boddie C, McGinty EE, et al. Media messages and perception of risk for 
Ebola virus infection, United States. Emerg Infect Dis 2017; 23: 108–11. 
80 Wang Y, McKee M, Torbica A, Stuckler D. Systematic Literature Review on the 
Spread of Health-related Misinformation on Social Media. Soc Sci Med 2019; 240: 
112552. 
81 Ng YJ, Yang ZJ, Vishwanath A. To fear or not to fear? Applying the social 
The Lancet Psychiatry Personal View: DRAFT 19 FOR RE-SUBMISSION 
07 April 2020 
28 
 
amplification of risk framework on two environmental health risks in Singapore. J 
Risk Res 2018; 21: 1487–501. 
82 Thompson RR, Garfin DR, Holman EA, Silver RC. Distress, Worry, and Functioning 
Following a Global Health Crisis: A National Study of Americans’ Responses to 
Ebola. Clin Psychol Sci 2017; 5: 513–21. 
83 Thompson RR, Jones NM, Holman EA, Silver RC. Media exposure to mass violence 
events can fuel a cycle of distress. Sci Adv 2019; 5: eaav3502. 
84 Garfin DR, Silver RC, Holman EA. The novel coronavirus (COVID-2019) outbreak: 
Amplification of public health consequences by media exposure. Heal Psychol 
2020; published online March 23. DOI:10.1037/hea0000875. 
85 Michie, West, Amlot R. Slowing down the covid-19 outbreak: changing behaviour 
by understanding it - The BMJ. BMJ Opin. 2020. 
https://blogs.bmj.com/bmj/2020/03/11/slowing-down-the-covid-19-outbreak-
changing-behaviour-by-understanding-it/ (accessed March 30, 2020). 
86 Michie S, van Stralen MM, West R. The behaviour change wheel: A new method for 
characterising and designing behaviour change interventions. Implement Sci 
2011; 6. DOI:10.1186/1748-5908-6-42. 
87 Rubin GJ, Potts HWW, Michie S. The impact of communications about swine flu 
(influenza A H1N1v) on public responses to the outbreak: results from 36 national 
telephone surveys in the UK. Health Technol Assess (Rockv) 2010; 14: 183–266. 
88 Freeman D, Garety PA, Bebbington PE, et al. Psychological investigation of the 
structure of paranoia. Br J Psychiatry 2005; 186. 
89 Torres, A. R., Fontenelle, L. F., Shavitt, R. G., Hoexter, M. Q., Pittenger, C., Miguel 
EC. Epidemiology, comorbidity, and burden of OCD. In: Pittenger C, ed. 
Obsessive-compulsive Disorder: Phenomenology, Pathophysiology, and Treatment. 
Oxford University Press, 2017. 
90 Abramowitz JS, McKay D, Storch EA. The Wiley Handbook of Obsessive 
Compulsive Disorders. Chichester, UK: John Wiley & Sons, Ltd, 2017 
DOI:10.1002/9781118890233. 
91 Peters GJY, Ruiter RAC, Kok G. Threatening communication: A critical re-analysis 
and a revised meta-analytic test of fear appeal theory. Health Psychol Rev 2013; 
7: S8–31. 
92 Public Health England. A Century of Public Health Marketing: Enduring public 
health challenges and revolutions in communication. 2017. 
https://publichealthengland.exposure.co/100-years-of-public-health-marketing 
(accessed April 7, 2020). 
93 Li YC, Bai WZ, Hirano N, Hayashida T, Hashikawa T. Coronavirus infection of rat 
dorsal root ganglia: Ultrastructural characterization of viral replication, transfer, 
and the early response of satellite cells. Virus Res 2012; 163: 628–35. 
94 Xu J, Zhong S, Liu J, et al. Detection of severe acute respiratory syndrome 
coronavirus in the brain: potential role of the chemokine Mig in pathogenesis. Clin 
Infect Dis 2005; 41: 1089–96. 
95 Li K, Wohlford-Lenane C, Perlman S, et al. Middle east respiratory syndrome 
coronavirus causes multiple organ damage and lethal disease in mice transgenic 
for human dipeptidyl peptidase 4. J Infect Dis 2016; 213: 712–22. 
96 Mao L, Wang M, Chen S, et al. Neurological manifestations of hospitalized patients 
with COVID-19 in Wuhan, China: a retrospective case series study. medRxiv 
The Lancet Psychiatry Personal View: DRAFT 19 FOR RE-SUBMISSION 
07 April 2020 
29 
 
2020; published online Feb 25. DOI:10.1101/2020.02.22.20026500. 
97 Talan J. COVID-19: Neurologists in Italy to colleagues in US: Look for poorly-
defined neurologic conditions in patients with the coronavirus. NeurologyToday. 
2020. 
https://journals.lww.com/neurotodayonline/blog/breakingnews/pages/post.aspx?P
ostID=920 (accessed March 27, 2020). 
98 Li YC, Bai WZ, Hashikawa T. The neuroinvasive potential of SARS-CoV2 may be at 
least partially responsible for the respiratory failure of COVID-19 patients. J Med 
Virol 2020; published online Feb 27. DOI:10.1002/jmv.25728. 
99 McCall S, Vilensky JA, Gilman S, Taubenberger JK. The relationship between 
encephalitis lethargica and influenza: a critical analysis. J Neurovirol 2008; 14: 
177–85. 
100 Desforges M, Le Coupanec A, Dubeau P, et al. Human coronaviruses and other 
respiratory viruses: underestimated opportunistic pathogens of the central 
nervous system? Viruses 2019; 12: 1–28. 
101 Dubé M, Le Coupanec A, Wong AHM, Rini JM, Desforges M, Talbot PJ. Axonal 
transport enables neuron-to-neuron propagation of human coronavirus OC43. J 
Virol 2018; 92: e00404-18. 
102 Andries K, Pensaert M. Immunofluorescence studies on the pathogenesis of 
hemagglutinating encephalomyelitis virus infection in pigs after oronasal 
inoculation. Am J Vet Res 1980; 41: 1372–8. 
103 Wrapp D, Wang N, Corbett KS, et al. Cryo-EM structure of the 2019-nCoV spike in 
the prefusion conformation. Science (80- ) 2020; 367: 1260–3. 
104 Zhang H, Penninger JM, Li Y, Zhong N, Slutsky AS. Angiotensin-converting enzyme 
2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential 
therapeutic target. Intensive Care Med 2020; 46: 586–90. 
105 Netland J, Meyerholz DK, Moore S, Cassell M, Perlman S. Severe Acute Respiratory 
Syndrome Coronavirus Infection Causes Neuronal Death in the Absence of 
Encephalitis in Mice Transgenic for Human ACE2. J Virol 2008; 82: 7264–75. 
106 Brann DH, Tsukahara T, Weinreb C, Logan DW, Datta SR. Non-neural expression 
of SARS-CoV-2 entry genes in the olfactory epithelium suggests mechanisms 
underlying anosmia in COVID-19 patients. bioRxiv Prepr; published online March. 
DOI:10.1101/2020.03.25.009084. 
107 Baig AM, Khaleeq A, Ali U, Syeda H. Evidence of the COVID-19 virus targeting the 
CNS: tissue distribution, host–virus interaction, and proposed neurotropic 
mechanisms. ACS Chem Neurosci 2020; 11: 995–8. 
108 Hamming I, Timens W, Bulthuis MLC, Lely AT, Navis GJ, van Goor H. Tissue 
distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first 
step in understanding SARS pathogenesis. J Pathol 2004; 203: 631–7. 
109 Desforges M, Miletti TC, Gagnon M, Talbot PJ. Activation of human monocytes 
after infection by human coronavirus 229E. Virus Res 2007; 130: 228–40. 
110 Chen G, Wu D, Guo W, et al. Clinical and immunologic features in severe and 
moderate Coronavirus Disease 2019. J Clin Invest 2020; published online March 
27. DOI:10.1172/JCI137244. 
111 Dantzer R, O’Connor JC, Freund GG, Johnson RW, Kelley KW. From inflammation 
to sickness and depression: when the immune system subjugates the brain. Nat 
Rev Neurosci 2008; 9: 46–56. 
The Lancet Psychiatry Personal View: DRAFT 19 FOR RE-SUBMISSION 
07 April 2020 
30 
 
112 Arabi YM, Harthi A, Hussein J, et al. Severe neurologic syndrome associated with 
Middle East respiratory syndrome corona virus (MERS-CoV). Infection 2015; 43: 
495–501. 
113 Bender SJ, Weiss SR. Pathogenesis of murine coronavirus in the central nervous 
system. J Neuroimmune Pharmacol 2010; 5: 336–54. 
114 Wessely S. History of postviral fatigue syndrome. Br Med Bull 1991; 47: 919–41. 
115 White PD, Thomas JM, Amess J, et al. Incidence, risk and prognosis of acute and 
chronic fatigue syndromes and psychiatric disorders after glandular fever. Br J 
Psychiatry 1998; 173: 475–81. 
116 Wessely S, Chalder T, Hirsch S, Pawlikowska T, Wallace P, Wright DJM. 
Postinfectious fatigue: prospective cohort study in primary care. Lancet 1995; 
345: 1333–8. 
117 Faull OK, Jenkinson M, Clare S, Pattinson KTS. Functional subdivision of the 
human periaqueductal grey in respiratory control using 7 tesla fMRI. Neuroimage 
2015; 113: 356–64. 
118 Hoffmann M, Kleine-Weber H, Schroeder S, et al. SARS-CoV-2 cell entry depends 
on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 
2020; 181: 1–10. 
119 Nabirotchkin S, Peluffo AE, Bouaziz J, Cohen D. Focusing on the unfolded protein 
response and autophagy related pathways to reposition common approved drugs 
against COVID-19. Preprints 2020; published online March 20. 
DOI:10.20944/preprints202003.0302.v1. 
120 Herrett E, Gallagher AM, Bhaskaran K, et al. Data Resource Profile: Clinical 
Practice Research Datalink (CPRD). Int J Epidemiol 2015; 44: 827–36. 
121 Stewart R, Soremekun M, Perera G, et al. The South London and Maudsley NHS 
Foundation Trust Biomedical Research Centre (SLAM BRC) case register: 
Development and descriptive data. BMC Psychiatry 2009; 9: 1–12. 
122 Jackson R, Kartoglu I, Stringer C, et al. CogStack - Experiences of deploying 
integrated information retrieval and extraction services in a large National Health 
Service Foundation Trust hospital. BMC Med Inform Decis Mak 2018; 18: 1–13. 
123 Needham EJ, Chou SHY, Coles AJ, Menon DK. Neurological implications of COVID-
19 infections (submitted). Lancet Neurol. 
124 Gostin OL, Bayer R, Fairchild AL. Ethical and Legal Challenges Posed by Severe 
Acute Respiratory Syndrome. JAMA 2003; 290: 3229–37. 
125 Townsend E, Nielsen E, Allister A, Cassidy SA. Key ethical questions for research 
during the COVID-19 Pandemic. Lancet Psychiatry 2020. 
126 Nuffield Council on Bioethics. Rapid policy briefing: Ethical considerations in 
responding to the COVID-19 pandemic. 2020. 
https://www.nuffieldbioethics.org/publications/covid-19 (accessed April 7, 2020). 
127 Chambers C. What’s next for registered reports? Nature 2019; 573: 187–9. 
128 Raguin G, Girard PM. Toward a global health approach: Lessons from the HIV and 
Ebola epidemics. Global Health 2018; 14: 114. 
 
